Infectious supernatant containing LCMV strain Clone 13 with a point mutation at glycoprotein Aa280 (asparagine to aspartic acid), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-pres
Infectious supernatant containing LCMV strain Clone 13 with a point mutation at nucleoprotein Aa400 (asparagine to serine), resulting in a loss of binding of the otherwise immunodominant and here mutated H-2Db-presented
Infectious cell culture supernatant. This Lymphocytic choriomeningitis virus [Armstrong-RHK 11.7.1989] is preserved under Viral Storage Medium -80°C.
Tests for the presence of mycoplasmae were positive.
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein Y72F mutatio
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein Y72F mutati
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutatio
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutati
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
